Cognyte Software (NASDAQ:CGNT - Free Report) had its target price boosted by Evercore ISI from $5.00 to $7.50 in a research note issued to investors on Wednesday, Benzinga reports. The firm currently has an in-line rating on the medical device company's stock.
A number of other research analysts have also issued reports on the company. Needham & Company LLC reiterated a hold rating on shares of Cognyte Software in a research report on Tuesday. StockNews.com downgraded shares of Cognyte Software from a strong-buy rating to a buy rating in a report on Thursday, March 7th.
View Our Latest Research Report on Cognyte Software
Cognyte Software Price Performance
Shares of NASDAQ CGNT traded down $0.30 during midday trading on Wednesday, hitting $6.97. 788,792 shares of the company's stock were exchanged, compared to its average volume of 451,398. Cognyte Software has a twelve month low of $3.75 and a twelve month high of $8.53. The firm has a market cap of $479.81 million, a P/E ratio of -11.85 and a beta of 1.68. The stock's 50 day moving average price is $7.61 and its 200-day moving average price is $6.10.
Institutional Trading of Cognyte Software
Hedge funds and other institutional investors have recently modified their holdings of the company. Tower Research Capital LLC TRC acquired a new stake in Cognyte Software during the fourth quarter valued at approximately $37,000. Quantbot Technologies LP bought a new position in shares of Cognyte Software in the first quarter valued at $45,000. M&T Bank Corp lifted its position in shares of Cognyte Software by 52.8% during the 1st quarter. M&T Bank Corp now owns 16,559 shares of the medical device company's stock valued at $56,000 after acquiring an additional 5,724 shares during the last quarter. Lazard Asset Management LLC acquired a new stake in shares of Cognyte Software during the 2nd quarter valued at $56,000. Finally, State of Wyoming boosted its stake in shares of Cognyte Software by 72.9% during the 2nd quarter. State of Wyoming now owns 9,794 shares of the medical device company's stock worth $60,000 after acquiring an additional 4,130 shares in the last quarter. Institutional investors own 72.92% of the company's stock.
About Cognyte Software
(
Get Free Report)
Cognyte Software Ltd. provides an investigative analytics software to governments and enterprises worldwide. Its Actionable Intelligence for a Safer World, an open software designed to help governments and enterprises accelerate and enhance the effectiveness of investigations. The company also offers network intelligence analytics, open source and threat intelligence analytics, and operational intelligence analytics solutions.
Featured Articles
Before you consider Cognyte Software, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cognyte Software wasn't on the list.
While Cognyte Software currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
